Combined PDCD1, BRAF and MAP2K7 Inhibition in BRAFV600E Colorectal Cancer: A Phase 2 Trial

DIAGNOSIS_AGE - Age at Diagnosis (phv00531234.v1.p1)
DIAGNOSIS_STAGE - Stage at diagnosis (phv00531236.v1.p1)
IS_TUMOR - Tumor status (phv00531244.v1.p1)
MMR_STATUS - Mismatch repair status (phv00531238.v1.p1)
PRIMARY_DISEASE - Case control status of the subject for Colorectal Cancer; all subjects are Colorectal Cancer patients. (phv00531233.v1.p1)
PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00531250.v1.p1)
RESPONSE - Responder or Non-responder to Therapy (phv00531237.v1.p1)
TUMOR_GRADE - Grade of primary tumor at time of sample collection (phv00531251.v1.p1)

ANALYTE_TYPE - Analyte Type (phv00531241.v1.p1)
BODY_SITE - Body site where sample was collected (phv00531245.v1.p1)
CONSENT - Consent group as determined by DAC (phv00531226.v1.p1)
CYCLE - Treatment cycle sample was collected (phv00531246.v1.p1)
DATA_TYPE - Type of sequencing used to generate data (phv00531242.v1.p1)
DAY - Treatment cycle day sample was collected (phv00531247.v1.p1)
NCELLS_EPI - Number of epithelial cells used to generate single cell RNA-seq (scRNAseq) data (phv00531243.v1.p1)
ON_TREATMENT - Was the sample collected before, on, or after treatment (phv00531248.v1.p1)
PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00531249.v1.p1)
RECIST - Response Evaluation Criteria in Solid Tumors (phv00531239.v1.p1)
SAMPLE_ID - Sample ID (phv00531240.v1.p1)
SAMPLE_ID - Sample ID (phv00531230.v1.p1)
SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00531252.v1.p1)
SUBJECT_ALIAS - Subject Aliases used in publication (phv00531232.v1.p1)
SUBJECT_ID - Subject ID (phv00531231.v1.p1)
SUBJECT_ID - Subject ID (phv00531225.v1.p1)
SUBJECT_ID - Subject ID (phv00531229.v1.p1)
SUBJECT_SOURCE - Source repository where subjects originate (phv00531228.v1.p1)